Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness and Safety of TachoSil® Fibrin Sealant Patch in Comparison to a Hydrogel Sealant for Supporting Dural Sealing Among Adult Inpatients in the United States: A Retrospective, Non-Inferiority, Cohort Study

NCT07927413 is registered in ClinicalTrials.gov with Corza Medical GmbH as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07927413 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness and Safety of TachoSil® Fibrin Sealant Patch in Comparison to a Hydrogel Sealant for Supporting Dural Sealing Among Adult Inpatients in the United States: A Retrospective, Non-Inferiority, Cohort Study
Lead sponsor
Corza Medical GmbH
Phase
Observational
Overall status
Recruiting
Start date
February 13, 2026
Completion date
November 16, 2026
Enrollment
600 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

cerebrospinal fluid (csf) leak, psuedomeningocele

Arms

As registered; 2 arms.

  • TachoSil® TachoSil®

    Adult inpatients who underwent neurological surgery with the use of TachoSil® for dural sealing support and were discharged from US hospitals from 01 January 2017 through 31 March 2026

  • DuraSeal® DuraSeal®

    Adult inpatients who underwent neurological surgery with the use of DuraSeal® for dural sealing support and were discharged from US hospitals from 01 January 2017 through 31 March 2026

Primary endpoints

Registered primary outcome measures; 1 primary.

  • Risk of Clinically Evident CSF Leak or Clinically Evident Pseudomeningocele Within 90 days post surgery

    A clinically evident CSF leak is defined as clear fluid leaking through the surgical incision or orifice verified by a glucose concentration test or β-2 transferrin test.

    A clinically evident pseudomeningocele is defined as a subcutaneous visible and/or palpable fluid accumulation adjacent to or at the site of surgical incision suspected to be CSF.

    If there is not a collection of CSF/pseudomeningocele, or active leak that can be sampled for β-2 transferrin test, but the participant had symptoms consistent with intracranial hypotension and/or an ex vacuo type subdural hematoma, the participant will be considered as having clinically evident CSF leak or pseudomeningocele.

Lead sponsor's other trials

Corza Medical GmbH, most recent start first.